-
-
-
-
-
-
-
-
-
-
7 . Periodical
Primary Analysis Results from an Open-Label Phase II Study of INCB039110, a Selective JAK1 Inhibitor, in Patients with Myelofibrosis
- 저자
- by Mascarenhas, John O; Talpaz, Moshe; Gupta, Vikas; Foltz, Lynda M; Savona, Michael R, et al.
- 소스
- Blood; December 2014, Vol. 124 Issue: 21 p714-714, 1p